Endospan
2 known investors
Endospan develops endovascular stent graft systems, including the NEXUS Multi-Branch Aortic Arch Stent Graft System, for repairing aortic aneurysms and dissections in patients whose anatomy is unsuitable for traditional EVAR/TEVAR therapy. The company operates in the medical device sector, serving the endovascular aortic repair market.
Founders & leadership
KM
Kevin MayberryChief Executive Officer
GD
Gadi DivaldChief Financial Officer
Investors Β· 2
Competitors Β· 2
by search overlap
Rf Surgical4 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies β including pacemakers, robotic-assisted surgery systems, and AI-driven health tools β used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Bioworld3 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Endospan for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Endospan do?
- Endospan develops endovascular stent graft systems, including the NEXUS Multi-Branch Aortic Arch Stent Graft System, for repairing aortic aneurysms and dissections in patients whose anatomy is unsuitable for traditional EVAR/TEVAR therapy. The company operates in the medical device sector, serving the endovascular aortic repair market.
- Who are Endospan's investors?
- Endospan's investors include Accelmed Partners, SCP Vitalife Partners.